Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunocontraceptives.

V C Stevens1, P D Griffin, W R Jones

  • 1Division of Reproductive Biology, Department of Obstetrics and Gynecology, Ohio State University, Columbus, Ohio, USA.

Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|November 23, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early weight gain trajectories in first episode anorexia: predictors of outcome for emerging adults in outpatient treatment.

Journal of eating disorders·2021
Same author

Use of Organic Acids To Improve the Chemical, Physical, and Microbial Attributes of Beef Strip Loins Stored at -1°C for 112 Days <sup>‡</sup>.

Journal of food protection·2019
Same author

Restructured Beef Steaks Manufactured Using Carbon Dioxide, Oxygen and Carbon Monoxide Gas.

Journal of food protection·2019
Same author

Statistical modelling of groundwater contamination monitoring data: A comparison of spatial and spatiotemporal methods.

The Science of the total environment·2018
Same author

Efficient and automatic methods for flexible regression on spatiotemporal data, with applications to groundwater monitoring.

Environmetrics·2016
Same author

Current status of antifertility vaccines using gonadotropin immunogens.

Immunology today·2014
Same journal

Ustekinumab Biosimilars versus Reference Ustekinumab for Moderate-to-Severe Plaque Psoriasis: A Pre-switch Systematic Review and Meta-analysis.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same journal

Correction: Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same journal

Gene Therapy Strategies for Uveal Melanoma: Adeno-associated Virus Delivery Challenges and Translational Opportunities.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same journal

Review of Quality Attributes and Analytical Methods Used for Comparative Analytical Assessment of Monoclonal Antibodies as Part of Successful Biosimilar Approvals in the United States and European Union.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same journal

Impact of Repeated Antigen Exposure on Humoral Tolerance: Antidrug Antibodies After Single-Dose Versus Multi-dose Adalimumab.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same journal

An Overview and Trend Analysis of Biosimilar Approvals in China.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
See all related articles

Immunocontraceptives offer novel, long-acting family planning with advantages over current methods. Further research and industry collaboration are needed for widespread availability of these advanced contraceptives.

Area of Science:

  • Reproductive Health
  • Immunology
  • Biotechnology

Background:

  • Immunocontraceptives represent a novel approach to family planning, offering potential advantages over existing methods.
  • These methods aim for long-acting (6-12 months) pregnancy protection without metabolic disturbances.
  • Potential applications exist for both men and women.

Purpose of the Study:

  • To review the current status of research and development in immunocontraceptive technologies.
  • To stimulate pharmaceutical industry engagement in the development and distribution of immunocontraceptives.

Main Methods:

  • Research focuses on immunocontraceptives targeting reproductive hormones (e.g., human chorionic gonadotropin, follicle-stimulating hormone, gonadotropin-releasing hormone).
  • Development also includes targeting gamete components (sperm and ova) and early pre-implantation conceptus products.

Related Experiment Videos

  • Clinical trials have begun for hormone-based prototypes in women and men.

    • Main Results:

    • Prototype immunocontraceptives based on human chorionic gonadotropin (women) and follicle-stimulating hormone (men) have reached clinical trials.
    • Ongoing research explores sperm, ovum, and gonadotropin-releasing hormone-based immunocontraceptives.
    • Overcoming individual immune response variations is crucial for consistent efficacy.

    Conclusions:

    • Immunocontraceptives hold significant promise for future family planning but require further research to address technical challenges.
    • Overcoming genetic variations in immune responses is key to ensuring predictable protection duration.
    • Collaboration between public sector agencies, governments, and industry is essential for development, manufacture, and distribution due to industry hesitancy.